Videos
Clinical Conversations by Experts
View all
Clinical Case-Based Learning: Virtual Tumor Board in Advanced Prostate Cancer
Treatment Considerations in First Line Setting of Metastatic Castration-Resistant Prostate Cancer
Artificial Intelligence in Prostate Cancer 2022
Featured Videos
PEACE 3 Trial Results Show Promise for Radium-223 and Enzalutamide in Asymptomatic mCRPC - Fred Saad
Durvalumab Plus Guadecitabine in Metastatic Kidney Cancer: Phase 1/2 Trial Results - Yousef Zakharia
Access and Utilization of Healthcare by Adults with Spina Bifida - Lindsay Hampson & Alejandro Lopez
Probing the Promising Future of Anti-HER2 Therapies for Micropapillary Bladder Cancer - Jeffrey Ross
Quality of Life and Patient-relevant Endpoints With Darolutamide in the ARASENS Trial - Karim Fizazi
A Urologist's Perspective on PSMA-Radioligand Therapy in the Treatment Setting of mCRPC - Neal Shore
Association of Inherited Mutations in DNA Repair Genes with Localized Prostate Cancer – Kara Maxwell
The Stakeholders in Operationalizing an Integrated PSMA Imaging and Therapies Clinic - Kendra Harris
Patient Selection for ADT Treatment with the Oral GnRH Antagonist in Clinical Practice - Ashley Ross
Prostate cancer genomic classifier Videos
Latest Videos
Bladder Cancer Videos
New Research Sheds Light on Alternative Treatments for Node-Positive Bladder Cancer - Martin Swinton
Probing the Promising Future of Anti-HER2 Therapies for Micropapillary Bladder Cancer - Jeffrey Ross
DNA Based Markers in High-risk Non-Muscle Invasive BCG Unresponsive Bladder Cancer - Alexander Wyatt
A Patient Perspective on High-Risk Non-Muscle Invasive BCG Unresponsive Bladder Cancer- Karen Sachse
Recent Conference Coverage
Conference Highlights Written by Physician-Scientist
ASCO 2023 Conference Highlights
- ASCO 2023: Digital Histopathology-Based Multimodal Artificial Intelligence Scores Predict Risk of Progression in a Randomized Phase III Trial in Patients with Nonmetastatic Castration-Resistant Prostate Cancer
- ASCO 2023: When to Play the Systemic Therapy Card
- ASCO 2023: When Is Stereotactic Ablative Body Radiotherapy an Option?
AUA 2023 Conference Highlights
- AUA 2023: Optimal Management of cN+ Muscle Invasive Bladder Cancer
- AUA 2023: Intermediate Risk NMIBC: Surveillance and Treatment Challenges
- AUA 2023: Perioperative Outcomes of Radical Cystectomy Following Neoadjuvant Gemcitabine, Cisplatin and Atezolizumab
Recent Physician-Scientist Review Articles
State of the Evidence Review Articles
Advanced Prostate Cancer
- PARP Inhibitor Combination Therapy: Approved Treatments for Metastatic Castrate-Resistant Prostate Cancer Patients
Written by Zachary Klaassen, MD, MSc Associate Professor of Urology Urologic Oncologist Medical College of Georgia, Georgia Cancer Center Augusta, GA & Rashid Sayyid, MD, MSc Urologic Oncology Fellow University of Toronto Toronto, Ontario, Canada
- PARP Inhibitor Therapy for Prostate Cancer Patients: Emerging Combinations
Written by Zachary Klaassen, MD, MSc Associate Professor of Urology Urologic Oncologist Medical College of Georgia, Georgia Cancer Center Augusta, GA and Rashid Sayyid, MD, MSc Urologic Oncology Fellow University of Toronto Toronto, Ontario, Canada
mHSPC
- Novel Targets and Treatment Developments in Metastatic Hormone Sensitive Prostate Cancer
Written by Zachary Klaassen, MD, MSc Associate Professor of Urology Urologic Oncologist Medical College of Georgia, Georgia Cancer Center Augusta, GA and Rashid Sayyid, MD, MSc Urologic Oncology Fellow University of Toronto Toronto, Ontario, Canada
- Prostate Radiotherapy for De Novo, Low Volume Metastatic Hormone Sensitive Prostate Cancer: Is There Benefit?
Written by Rashid Sayyid, MD, MSc and Zachary Klaassen, MD, MSc
Transformative Evidence
Curated by Clinicians: Educational Forum with Videos, Abstracts and Conference Information
Trials in Progress
Curated by Clinicians: Educational Forum with Videos, Abstracts and Conference Information